Evidence map›Paper›PMID 26562321›Full record

Observational studyVaccine2015

Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.

Robert G Deiss, John C Arnold, Wei-Ju Chen, Sara Echols, Mary P Fairchok, Christina Schofield, Patrick J Danaher, Erin McDonough, Michelande Ridoré, Deepika Mor and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Vaccine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  9. US food allergy patients' experiences, priorities, and needs: A qualitative study.The journal of allergy and clinical immunology. Global · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Robert G DeissInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States; Naval Medical Center of San Diego, San Diego, CA, United States; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States. Electronic address: robert.g.deiss.ctr@mail.mil.
John C ArnoldNaval Medical Center of San Diego, San Diego, CA, United States.
Wei-Ju ChenInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States.
Sara EcholsInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States; Naval Medical Center of San Diego, San Diego, CA, United States; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States.
Mary P FairchokInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States; Madigan Army Medical Center, Tacoma, WA, United States.
Christina SchofieldMadigan Army Medical Center, Tacoma, WA, United States.
Patrick J DanaherSan Antonio Military Medical Center, San Antonio, TX, United States.
Erin McDonoughThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States; Naval Health Research Center, San Diego, CA, United States.
Michelande RidoréInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States.
Deepika MorInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States.
Timothy H BurgessWalter Reed National Military Medical Center, Bethesda, MD, United States.
Eugene V MillarInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States. Electronic address: emillar@idcrp.org.
Henry M. Jackson Foundation · USMadigan Army Medical Center · USNaval Medical Center San Diego · USUniformed Services University of the Health Sciences · USNaval Health Research Center · USSan Antonio Military Medical Center · USWalter Reed National Military Medical Center · US

Funding

DATA CENTER FOR EPIDEMIOLOGIC INVESTIGATIONS OF HIVN01AI005072 · NIAID · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MCKINLAY, SONJA M · 1990 to 1994
–
NIAID NIH HHS Y01 AI005072NIAID NIH HHS [Y1-AI-5072
6 · The paper itself

Abstract

backgroundThe moderate level of protection conferred by influenza vaccines is well-known, but the vaccine's ability to attenuate symptom severity among vaccinated individuals (i.e., vaccine failures) has not been established.

methodsWe enrolled otherwise healthy adults who presented with influenza-like illness (ILI) at five US military hospitals between 2009 and 2014. Influenza was diagnosed and subtyped by PCR. Individual and composite severity scores were compared between those who had vs. had not received the seasonal influenza vaccine >14 days prior to enrollment.

resultsA total of 155 cases of influenza (A/H1N1, n=69; A/H3N2, n=66; A/untyped, n=3; B, n=17) were identified, of whom 111 (72%; A/H1N1, n=44; A/H3N2, n=52; A/untyped, n=3; B, n=12) had been vaccinated. Women were significantly less likely to be vaccinated than men (49% vs. 89%; p<0.01). In multivariate analysis, vaccinated individuals were significantly less likely to report a fever >101°F (OR 0.24; 95% CI [0.10, 0.62]) and more likely to report myalgias (OR 3.31; 95% CI [1.22, 8.97]) than vaccinated individuals. Among patients with A/H3N2 infection, upper respiratory and total symptom severity scores were significantly lower for vaccinated patients during the first 2 days of illness, and differences in total symptom severity persisted over 7 days (p<0.05 for all comparisons). Differences across additional symptom categories (lower respiratory and systemic) were also observed throughout 7 days of illness in bivariate analyses. Differences in symptom severity were not observed between vaccinated and unvaccinated participants with A/H1N1 infection.

conclusionsAmong patients with A/H3N2 infection, receipt of seasonal influenza vaccine was associated with reduced symptom severity. Patient-centered discussion about the benefits of influenza vaccination should be expanded to include the possibility that the vaccine could attenuate symptoms.

Indexed as

Severity of Illness IndexAdultFemaleHumansInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInfluenza VaccinesLongitudinal StudiesMaleMilitary PersonnelUnited StatesInfluenza VaccinesInfluenzaMilitarySeverityVaccine

Identifiers

PMID26562321
PMCPMC4684491
OpenAlexW2107164582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.